Adding IV Amiodarone to the EMS Algorithm for Cardiac Arrest Due
... life-threatening arrhythmias, who are thoroughly familiar with the risks and benefits of amiodarone therapy, and who have access to facilities adequate for monitoring the effectiveness and side effects of treatment. Hypotension is the most common adverse effect seen with IV amiodarone and may be rel ...
... life-threatening arrhythmias, who are thoroughly familiar with the risks and benefits of amiodarone therapy, and who have access to facilities adequate for monitoring the effectiveness and side effects of treatment. Hypotension is the most common adverse effect seen with IV amiodarone and may be rel ...
LWW PPT Slide Template Master
... Common Cardiac Diseases and Treatments • Signs of heart problems – Cyanosis: bluish tinge – Pallor: paleness – Edema: swelling of tissues – Diaphoresis: excessive sweating – Angina (angina pectoris): severe chest pain ...
... Common Cardiac Diseases and Treatments • Signs of heart problems – Cyanosis: bluish tinge – Pallor: paleness – Edema: swelling of tissues – Diaphoresis: excessive sweating – Angina (angina pectoris): severe chest pain ...
presentation source
... - decreases risk of coronary events in patients with coronary artery disease. Lipid-lowering agents - used if total cholesterol is greater than 4.8mmol/L ...
... - decreases risk of coronary events in patients with coronary artery disease. Lipid-lowering agents - used if total cholesterol is greater than 4.8mmol/L ...
BLOOD VOLUME IN CONGESTIVE HEART FAILURE` Discussions
... diabetes, peptic ulcer, epilepsy and other neurological disorders, and convalescent pneumonia. In fifty-five of the control patients who remained largely confined to bed during their hospital stay, an initial blood volume determination was made shortly after admission and was repeated after a varyin ...
... diabetes, peptic ulcer, epilepsy and other neurological disorders, and convalescent pneumonia. In fifty-five of the control patients who remained largely confined to bed during their hospital stay, an initial blood volume determination was made shortly after admission and was repeated after a varyin ...
Theory PPTs - Cabrillo College
... elevations in cardiac troponin, high risk for MI • If occludes flow for prolonged period,ST-segment elevation MI occurs, clot rich in Thrombin • Prompt fibrinolysis( TPA, Activase, TNKase) or PTCA, may limit size, increase survival ...
... elevations in cardiac troponin, high risk for MI • If occludes flow for prolonged period,ST-segment elevation MI occurs, clot rich in Thrombin • Prompt fibrinolysis( TPA, Activase, TNKase) or PTCA, may limit size, increase survival ...
Why does pulmonary venous pressure rise after onset of LV
... PVP increased from the control value of 12 to only 16 (EDPVR) at a volume of 110 ml increased from 14 to 38 mmHg. Thus pulmonary congestion could not be created ml. In response to this dramatic increase in LV diastolic in this model simply by inducing a profound reduction in stiffness, LV Ped increa ...
... PVP increased from the control value of 12 to only 16 (EDPVR) at a volume of 110 ml increased from 14 to 38 mmHg. Thus pulmonary congestion could not be created ml. In response to this dramatic increase in LV diastolic in this model simply by inducing a profound reduction in stiffness, LV Ped increa ...
Role of Nitric Oxide in the Systemic and Pulmonary Circulation of
... seemed unrelated to NO production given the lack of cardioactive effects by SNP, in analogy with effects previously reported in man (Hishikawa et al., ’92). This is further supported from data obtained in other individuals of T.scripta (N = 4) under identical experimental conditions. As shown in Tab ...
... seemed unrelated to NO production given the lack of cardioactive effects by SNP, in analogy with effects previously reported in man (Hishikawa et al., ’92). This is further supported from data obtained in other individuals of T.scripta (N = 4) under identical experimental conditions. As shown in Tab ...
Cardiac PET and PET/CT Imaging Practice Guidelines
... • Seventy-five percent of HF cases have antecedent hypertension. • About 22 percent of male and 46 percent of female heart attack (MI) victims will be disabled with HF within six years. • At age 40, the lifetime risk of developing HF for both men and women is one in five. • At age 40, the lifeti ...
... • Seventy-five percent of HF cases have antecedent hypertension. • About 22 percent of male and 46 percent of female heart attack (MI) victims will be disabled with HF within six years. • At age 40, the lifetime risk of developing HF for both men and women is one in five. • At age 40, the lifeti ...
Cardiology Library 2008 3 أقراص ديفيدي تحتوي على مئات الكتب و
... ABC of arterial and venous disease Atherosclerosis and Heart DiseaseGuidelines Pocket Consultant Cardiology 100 Questions in Cardiology A Nurse's Guide to Caring for Cardiac Intervention Patients ABC of Antithrombotic Therapy Adult Congenital Heart Disease-A PRACTICAL GUIDE Atlas of Cardiometabolic ...
... ABC of arterial and venous disease Atherosclerosis and Heart DiseaseGuidelines Pocket Consultant Cardiology 100 Questions in Cardiology A Nurse's Guide to Caring for Cardiac Intervention Patients ABC of Antithrombotic Therapy Adult Congenital Heart Disease-A PRACTICAL GUIDE Atlas of Cardiometabolic ...
High prevalence of occult left heart disease in scleroderma-pulmonary hypertension
... pulmonary parenchymal disease, veno-occlusive disease, post-capillary pulmonary venous hypertension (PVH) from left heart dysfunction or combinations of these abnormalities [2]. The pulmonary vasodilator drugs approved for PAH may have deleterious effects or be ineffective if administered to patient ...
... pulmonary parenchymal disease, veno-occlusive disease, post-capillary pulmonary venous hypertension (PVH) from left heart dysfunction or combinations of these abnormalities [2]. The pulmonary vasodilator drugs approved for PAH may have deleterious effects or be ineffective if administered to patient ...
Management of Stable Angina Pectoris
... Second revascularization procedure more likely in first year after PTCA Surgery patients more likely to be angina free at one year ...
... Second revascularization procedure more likely in first year after PTCA Surgery patients more likely to be angina free at one year ...
Pre-Hospital Thrombolysis Aditi Vaishnav , Avani Vaishnav , Santosh Khandekar
... causing the infarct (thrombolysis) followed by trials of primary angioplasty in the 1990s. Treatment regimes for patients experiencing AMI have been presented out in evidence based clinical guidelines established through a combination of professional and voluntary bodies.3,4 Not all patients are sui ...
... causing the infarct (thrombolysis) followed by trials of primary angioplasty in the 1990s. Treatment regimes for patients experiencing AMI have been presented out in evidence based clinical guidelines established through a combination of professional and voluntary bodies.3,4 Not all patients are sui ...
E-Routes and Lines
... There are many classifications of routes that share important features but then differ in detail. For example, if a drug is given sub-lingually (placed under the tongue and allowed to dissolve) then, technically, the route is transmucosal because the drug is absorbed through the mucous membrane, it ...
... There are many classifications of routes that share important features but then differ in detail. For example, if a drug is given sub-lingually (placed under the tongue and allowed to dissolve) then, technically, the route is transmucosal because the drug is absorbed through the mucous membrane, it ...
efficacy of thrombolytic therapy in preserving left ventricular function
... study showed a better left ventricular function in group receiving thrombolytic therapy. Patients who could not be given thrombolytic therapy showed deteriorating left ventricular function which progressed even after one week. It is concluded that addition of thrombolytic therapy definitely improves ...
... study showed a better left ventricular function in group receiving thrombolytic therapy. Patients who could not be given thrombolytic therapy showed deteriorating left ventricular function which progressed even after one week. It is concluded that addition of thrombolytic therapy definitely improves ...
Plavix® Consultants Kit Blue
... Cumulative CRUSADE data (adjusted) through September 2004. Adapted with permission from CRUSADE Web site. Available at: http://www.crusadeqi.com. Accessed February 10, 2005. ...
... Cumulative CRUSADE data (adjusted) through September 2004. Adapted with permission from CRUSADE Web site. Available at: http://www.crusadeqi.com. Accessed February 10, 2005. ...
Atrial fibrillation progression and management: A 5-year
... years; two females), all with hypertensive cardiomyopathy and on amiodarone therapy. In these three patients, the last attempt at cardioversion for recurrent persistent AF was performed by a 200-J biphasic external shock, which restored sinus rhythm but was followed by frequent atrial premature depo ...
... years; two females), all with hypertensive cardiomyopathy and on amiodarone therapy. In these three patients, the last attempt at cardioversion for recurrent persistent AF was performed by a 200-J biphasic external shock, which restored sinus rhythm but was followed by frequent atrial premature depo ...
Oxygen Cost of Electrical Activation of the Heart
... the accompanying carrier preamplifier and recording system were similar to those used with the Walton-Brodie strain gauge arch and permitted detecting changes of tension in the right ventricular segment of less than 0.5 g. The choice of the right ventricle for the more sensitive strain gauge arch wa ...
... the accompanying carrier preamplifier and recording system were similar to those used with the Walton-Brodie strain gauge arch and permitted detecting changes of tension in the right ventricular segment of less than 0.5 g. The choice of the right ventricle for the more sensitive strain gauge arch wa ...
Presenting a Technical Report - Lock Haven University of
... (CAS) in the general adult population – This recommendation applies to adults without neurological signs or symptoms, including a history of transient ischemic attacks or stroke. If otherwise eligible, an individual who has a carotid-area transient ischemic attack should be evaluated promptly for co ...
... (CAS) in the general adult population – This recommendation applies to adults without neurological signs or symptoms, including a history of transient ischemic attacks or stroke. If otherwise eligible, an individual who has a carotid-area transient ischemic attack should be evaluated promptly for co ...
BME lecture 6 - pv loops (Sept 14, 2004)
... (below) during continuous flow (CF) ventricular assist device (VAD) support at 75% and 100% bypass. Notice that in normal ventricle model, the only effect is a leftward shift of PV loop. ...
... (below) during continuous flow (CF) ventricular assist device (VAD) support at 75% and 100% bypass. Notice that in normal ventricle model, the only effect is a leftward shift of PV loop. ...
Bleeding and Shock - Paramedic Association of Manitoba
... Perfusion occurs when blood circulates through tissues or an organ, to provide the necessary oxygen and nutrients and remove waste products. ...
... Perfusion occurs when blood circulates through tissues or an organ, to provide the necessary oxygen and nutrients and remove waste products. ...
Cardiopulmonary Resuscitation
... • It is a b receptor agonist in low doses and an a receptor agonist in high doses. • Beneficial during cardiac arrest mainly because of it’s a receptor properties • It increases myocardial oxygen consumption by increasing heart rate and afterload. • Dose: 1 mg every 3-5 minutes in adults. • Can be g ...
... • It is a b receptor agonist in low doses and an a receptor agonist in high doses. • Beneficial during cardiac arrest mainly because of it’s a receptor properties • It increases myocardial oxygen consumption by increasing heart rate and afterload. • Dose: 1 mg every 3-5 minutes in adults. • Can be g ...
Fasudil reduces monocrotaline-induced pulmonary arterial hypertension: comparison with bosentan and sildenafil
... RVSP is already elevated at day 14 [16]. We specifically chose to study treatment of PAH that had already developed rather than a prevention set-up, and examined the effects of 14 days of treatment with bosentan and sildenafil, two drugs that are currently first-line treatments in PAH. Cardiac funct ...
... RVSP is already elevated at day 14 [16]. We specifically chose to study treatment of PAH that had already developed rather than a prevention set-up, and examined the effects of 14 days of treatment with bosentan and sildenafil, two drugs that are currently first-line treatments in PAH. Cardiac funct ...
Dysnatraemia in Heart Failure: A Descriptive Study
... stay 3. To correlate between the serum sodium levels with other variables such as SBP, blood urea levels, and serum creatinine levels at the time of admission in heart failure patients. ...
... stay 3. To correlate between the serum sodium levels with other variables such as SBP, blood urea levels, and serum creatinine levels at the time of admission in heart failure patients. ...
Antihypertensive drug
Antihypertensives are a class of drugs that are used to treat hypertension (high blood pressure). Antihypertensive therapy seeks to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Evidence suggests that reduction of the blood pressure by 5 mmHg can decrease the risk of stroke by 34%, of ischaemic heart disease by 21%, and reduce the likelihood of dementia, heart failure, and mortality from cardiovascular disease. There are many classes of antihypertensives, which lower blood pressure by different means. Among the most important and most widely used drugs are thiazide diuretics, calcium channel blockers, ACE inhibitors, angiotensin II receptor antagonists (ARBs), and beta blockers.Which type of medication to use initially for hypertension has been the subject of several large studies and resulting national guidelines. The fundamental goal of treatment should be the prevention of the important endpoints of hypertension, such as heart attack, stroke and heart failure. Patient age, associated clinical conditions and end-organ damage also play a part in determining dosage and type of medication administered. The several classes of antihypertensives differ in side effect profiles, ability to prevent endpoints, and cost. The choice of more expensive agents, where cheaper ones would be equally effective, may have negative impacts on national healthcare budgets. As of 2009, the best available evidence favors the thiazide diuretics as the first-line treatment of choice for high blood pressure when drugs are necessary. Although clinical evidence shows calcium channel blockers and thiazide-type diuretics are preferred first-line treatments for most people (from both efficacy and cost points of view), an ACE inhibitor is recommended by NICE in the UK for those under 55 years old.